Basal and apical regulation of VEGF-A and placenta growth factor in the RPE/choroid and primary RPE

Molecular Vision

Volumn 21, Issue , 2015, Pages 736-748

  Klettner, Alexa ^a   Kaya, Leyla ^a   Flach, Janina ^a   Lassen, Jens ^a   Treumer, Felix ^a   Roider, Johann ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PLACENTAL GROWTH FACTOR; POLYVINYLIDENE FLUORIDE; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; PLACENTA PROTEIN; TRANSCRIPTION FACTOR SP1;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BRUCH MEMBRANE; CELL CULTURE; CELL DEDIFFERENTIATION; CELL POLARITY; CHOROID; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; NONHUMAN; ORGAN CULTURE TECHNIQUE; PIG; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SUBRETINAL NEOVASCULARIZATION; SUPERNATANT; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; RETINAL PIGMENT EPITHELIUM; SECRETION (PROCESS);

ANIMALS; CELLS, CULTURED; CHOROID; NF-KAPPA B; ORGAN CULTURE TECHNIQUES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLACENTA GROWTH FACTOR; PREGNANCY PROTEINS; RETINAL PIGMENT EPITHELIUM; SP1 TRANSCRIPTION FACTOR; SUS SCROFA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84937541714     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allel. Nature 1996; 380:435-9. [PMID: 8602241].
2. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O’Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-42. [PMID: 8602242].
3. Klettner A. Physiological functions of VEGF in the retina and its possible implications of prolonged anti-VEGF therapy. In: Vascular Endothelial Growth Factor: Biology, Regulation and Clinical significance, Nova Publishing, Editors: Marecellus L. Parker; 2013; p. 117–136.
4. Lu M, Adamis AP. Molecular biology of choroidal neovascularization. Ophthalmol Clin North Am 2006; 19:323-34. [PMID: 16935207].
5. Scholl S, Kirchhof J, Augustin AJ. Pathophysiology of macular edema. Ophthalmologica 2010; 224:Suppl.18-15. [PMID: 20714176].
6. Klettner A, Roider J. Treating age-related macular degeneration-interaction of VEGF-antagonists with their target. Mini Rev Med Chem 2009; 9:1127-35. [PMID: 19689408].
7. Klettner A., Roider J. Mechanisms of Pathological VEGF Production in the Retina and Modification with VEGF-antagonists. In Oxidative Stress in Applied Basic Research and Clincial Practice, Studies on Retinal and Choroidal Disorders, Edts Stratton RD, Hauswirth WW, Gardner TW. Springer, 2012. p. 277–306.
8. Kannan R, Zhang N, Sreekumar PG, Spee CK, Rodriguez A, Barron E, Hinton DR. Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. Mol Vis 2006; 12:1649-59. [PMID: 17200665].
9. Klettner A, Roider J. Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinases. Graefes Arch Clin Exp Ophthalmol 2009; 247:1487-92. [PMID: 19603178].
10. Faby H, Hillenkamp J, Roider J, Klettner A. Hyperthermia-induced upregulation of vascular endothelial growth factor in retinal pigment epithelial cells is regulated by mitogen-activated protein kinases. Graefes Arch Clin Exp Ophthalmol 2014; 252:1737-45. [PMID: 25047875].
11. Adamis AP, Shima DT, Yeo KT, Yeo TK, Brown LF, Berse B, D’Amore PA, Folkman J. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun 1993; 193:631-8. [PMID: 8512562].
12. Klettner A, Westhues D, Lassen J, Bartsch S, Roider J. Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor κB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway. Mol Vis 2013; 19:281-91. [PMID: 23401656].
13. Klettner A, Roider J. Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways. Invest Ophthalmol Vis Sci 2008; 49:4523-7. [PMID: 18441313].
14. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, VandenDriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7:575-83. [PMID: 11329059].
15. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, Kroll J, Plaisance S, De Mol M, Bono F, Kliche S, Fellbrich G, Ballmer-Hofer K, Maglione D, Mayr-Beyrle U, Dewerchin M, Dombrowski S, Stanimirovic D, Van Hummelen P, Dehio C, Hicklin DJ, Persico G, Herbert JM, Communi D, Shibuya M, Collen D, Conway EM, Carmeliet P. Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003; 9:936-43. [PMID: 12796773].
16. Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994; 269:25646-54. [PMID: 7929268].
17. Rakic JM, Lambert V, Devy L, Luttun A, Carmeliet P, Claes C, Nguyen L, Foidart JM, Noël A, Munaut C. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 2003; 44:3186-93. [PMID: 12824270].
18. Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. Mol Aspects Med 2012; 33:295-317. [PMID: 22542780].
19. Kay P, Yang YC, Paraoan L. Directional protein secretion by the retinal pigment epithelium: roles in retinal health and the development of age-related macular degeneration. J Cell Mol Med 2013; 17:833-43. [PMID: 23663427].
20. Becerra SP, Fariss RN, Wu YQ, Montuenga LM, Wong P, Pfeffer BA. Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution. Exp Eye Res 2004; 78:223-34. [PMID: 14729355].
21. Maminishkis A, Chen S, Jalickee S, Banzon T, Shi G, Wang FE, Ehalt T, Hammer JA, Miller SS. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci 2006; 47:3612-24. [PMID: 16877436].
22. Treumer F, Klettner A, Baltz J, Hussain AA, Miura Y, Brinkmann R, Roider J, Hillenkamp J. Vectorial release of matrix metalloproteinases (MMPs) from porcine RPE-choroid explants following selective retina therapy (SRT): towards slowing the macular ageing process. Exp Eye Res 2012; 97:63-72. [PMID: 22387137].
23. Miura Y, Klettner A, Roider J. VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: possible participation of intracellular glutathione. Invest Ophthalmol Vis Sci 2010; 51:4848-55. [PMID: 20435596].
24. Dithmer M, Fuchs S, Shi Y, Schmidt H, Richert E, Roider J, Klettner A. Fucoidan reduces secretion and expression of vascular endothelial growth factor in the retinal pigment epithelium and reduces angiogenesis in vitro. PLoS ONE 2014; 9:e89150-[PMID: 24558482].
25. Miura Y, Klettner A, Noelle B, Hasselbach H, Roider J. Change of morphological and functional characteristics of retinal pigment epithelium cells during cultivation of retinal pigment epithelium-choroid perfusion tissue culture. Ophthalmic Res 2010; 43:122-33. [PMID: 19887877].
26. Terasaki H, Shirasawa M, Otsuka H, Yamashita T, Uchino E, Hisatomi T, Sonoda S, Sakamoto T. Different Effects of Thrombin on VEGF Secretion, Proliferation, and Permeability in Polarized and Non-polarized Retinal Pigment Epithelial Cells. Curr Eye Res 2014; 13:1-10. [PMID: 25310246].
27. Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, Alitalo K, Kroon ME, Kijlstra A, van Hinsbergh VW, Schlingemann RO. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 1999; 155:421-8. [PMID: 10433935].
28. Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, Darland DC, Young MJ, D’Amore PA. Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS ONE 2008; 3:e3554-[PMID: 18978936].
29. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D’Amore PA. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci USA 2009; 106:18751-6. [PMID: 19841260].
30. Hollborn M, Tenckhoff S, Seifert M, Köhler S, Wiedemann P, Bringmann A, Kohen L. Human retinal epithelium produces and responds to placenta growth factor. Graefes Arch Clin Exp Ophthalmol 2006; 244:732-41. [PMID: 16341703].
31. Kunchithapautham K, Rohrer B. Sublytic membrane-attack-complex (MAC) activation alters regulated rather than constitutive vascular endothelial growth factor (VEGF) secretion in retinal pigment epithelium monolayers. J Biol Chem 2011; 286:23717-24. [PMID: 21566137].
32. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhame L, Charon D, Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991; 266:15771-81. [PMID: 1874734].
33. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinosiytol 3-kinase 2-(4-morpholinyl)-8-phenyl-4H–1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269:5241-8. [PMID: 8106507].
34. Schust J, Sperl B, Hollis A, Mayer TU, Berg T. Stattic: A small-molecule inhibitor of STAT3 activation and dimerisation. Chem Biol 2006; 13:1235-42. [PMID: 17114005].
35. Chun YS, Yeo EJ, Choi E, Teng CM, Bae JM, Kim MS, Park JW. Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. Biochem Pharmacol 2001; 61:947-54. [PMID: 11286986].
36. Tobe M, Isobe Y, Tomizawa H, Nagasaki T, Takahashi H, Fukazawa T, Hayashi H. Discovery of quinazolines as a novel structure class of potent inhibitors of NF-kB activation. Bioorg Med Chem 2003; 11:383-91. [PMID: 12517433].
37. Sleiman SF, Langley BC, Basso M, Berlin J, Xia L, Payappilly JB, Kharel MK, Guo H, Marsh JL, Thompson LM, Mahishi L, Ahuja P, MacLellan WR, Geschwind DH, Coppola G, Rohr J, Ratan RR. Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration. J Neurosci 2011; 31:6858-70. [PMID: 21543616].
38. Lisnock J, Tebben A, Frantz B, O’Neill EA, Croft G, O’Keefe SJ, Li B, Hacker C, de Laszlo S, Smith A, Libby B, Liverton N, Hermes J, LoGrasso P. Molecular basis for p38 protein kinase inhibitor specificity. Biochemistry 1998; 37:16573-81. [PMID: 9843424].
39. Strawn LM, McMahon G, App H, Schreck R, Kuchler WR, Longhi MP, Hui TH, Tang C, Levitzki A, Gazit A, Chen I, Keri G, Orfi L, Risau W, Flamme I, Ullrich A, Hirth KP, Shawver LK. Flk-1 as a target for tumor growth inhibition. Cancer Res 1996; 56:3540-5. [PMID: 8758924].
40. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351:95-105. [PMID: 10998351].
41. Hardenbol P, Van Dyke MW. In vitro inhibition of c-myc transcription by mithramycin. Biochem Biophys Res Commun 1992; 185:553-8. [PMID: 1535193].
42. DeNiro M, Al-Halafi A, Al-Mohanna FH, Alsmadi O, Al-Mohanna FA. Pleiotropic effects of YC-1 selectively inhibit pathological retina neovascularisation and promote physiological revascularization in a mouse model of oxygen-induced retinopathy. Mol Pharmacol 2010; 77:348-67. [PMID: 20008515].
43. Roberts NA, Marber MS, Avkiran M. Specificity of action of bisindolylmaleimide protein kinase C inhibitors: do they inhibit the 70 kDa ribosomal S6 kinase in cardiac myocytes? Biochem Pharmacol 2004; 68:1923-8. [PMID: 15476663].
44. Deacon K, Onion D, Kumari R, Watson SA, Knox AJ. Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer. J Biol Chem 2012; 287:39967-81. [PMID: 22992725].
45. Nagineni CN, Kommineni VK, William A, Detrick B, Hooks JJ. Regulation of VEGF expression in human retinal cells by cytokines: implications for the role of inflammation in age-related macular degeneration. J Cell Physiol 2012; 227:116-26. [PMID: 21374591].
46. Klettner A. Oxidative stress induced cellular signaling in RPE cells. Front Biosci(ScholEd) 2012; 4:392-411. Schol Ed[PMID: 22202067].
47. Byeon SH, Lee SC, Choi SH, Lee HK, Lee JH, Chu YK, Kwon OW. Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt. Invest Ophthalmol Vis Sci 2010; 51:1190-7. [PMID: 19834034].
48. De Falco S. The discovery of placenta growth factor and its biological activity. Exp Mol Med 2012; 44:1-9. [PMID: 22228176].
49. Cramer M, Nagy I, Murphy BJ, Gassmann M, Hottiger MO, Georgiev O, Schaffner W. NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells. Biol Chem 2005; 386:865-72. [PMID: 16164411].
50. Shaw JH, Lloyd PG. Post-transcriptional regulation of placenta growth factor mRNA by hydrogen peroxide. Microvasc Res 2012; 84:155-60. [PMID: 22683469].